Skip to main navigation Skip to search Skip to main content

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors

  • Jinhyuk Bhin
  • , Mariana Paes Dias
  • , Ewa Gogola
  • , Frank Rolfs
  • , Sander R. Piersma
  • , Roebi de Bruijn
  • , Julian R. de Ruiter
  • , Bram van den Broek
  • , Alexandra A. Duarte
  • , Wendy Sol
  • , Ingrid van der Heijden
  • , Christina Andronikou
  • , Taina S. Kaiponen
  • , Lara Bakker
  • , Cor Lieftink
  • , Ben Morris
  • , Roderick L. Beijersbergen
  • , Marieke van de Ven
  • , Connie R. Jimenez
  • , Lodewyk F. A. Wessels*
  • Sven Rottenberg*, Jos Jonkers*
*Corresponding author for this work
  • Netherlands Cancer Institute
  • Yonsei University
  • University of Bern
  • University of Bern, Institute of Animal Pathology

Research output: Contribution to journalArticleAcademicpeer-review

31 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Keyphrases